← back to search

Andrea N. Burnett‐Hartman

Kaiser Permanente · US
Area of research
Oncology · Pathology and Forensic Medicine
Research interest
Research interests include Colorectal Cancer Screening and Detection, Genetic factors in colorectal cancer, Global Cancer Incidence and Screening, and Colorectal Cancer Treatments and Studies.
h-index
35
citations
5,114
works
251
NIH funding
primary concept
Medicine
email

Recent publications

Using gene-environment interactions to explore pathways for colorectal cancer risk
EBioMedicine 2025cited by 2position: middledoi
Impact of weight loss on cancer-related proteins in serum: results from a cluster randomised controlled trial of individuals with type 2 diabetes
EBioMedicine 2024cited by 6position: middledoi
Two genome-wide interaction loci modify the association of nonsteroidal anti-inflammatory drugs with colorectal cancer
Science Advances 2024cited by 6position: middledoi
Characterization of Additive Gene–environment Interactions For Colorectal Cancer Risk
Epidemiology 2024cited by 3position: middledoi
A picture is worth a thousand words: advancing the use of visualization tools in implementation science through process mapping and matrix heat mapping
Implementation Science Communications 2023cited by 35position: middledoi
Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations
Nature Communications 2023cited by 27position: middledoi
Genome-wide interaction analysis of folate for colorectal cancer risk
American Journal of Clinical Nutrition 2023cited by 11position: middledoi
Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes
Gastroenterology 2023cited by 6position: middledoi
Validation of a Genetic-Enhanced Risk Prediction Model for Colorectal Cancer in a Large Community-Based Cohort
Cancer Epidemiology Biomarkers & Prevention 2023cited by 6position: middledoi
Combining Asian-European Genome-Wide Association Studies of Colorectal Cancer Improves Risk Prediction Across Race and Ethnicity
medRxiv 2023cited by 1position: middledoi
Genetic regulation of OAS1 nonsense-mediated decay underlies association with COVID-19 hospitalization in patients of European and African ancestries
Nature Genetics 2022cited by 136position: middledoi
Evaluation of Harms Reporting in U.S. Cancer Screening Guidelines
Annals of Internal Medicine 2022cited by 22position: lastdoi
An Update on the Epidemiology, Molecular Characterization, Diagnosis, and Screening Strategies for Early-Onset Colorectal Cancer
Gastroenterology 2021cited by 300position: firstdoi
Genetic architectures of proximal and distal colorectal cancer are partly distinct
Gut 2021cited by 79position: middledoi
Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study
American Journal of Clinical Nutrition 2021cited by 51position: middledoi
Genetic regulation of <i>OAS1</i> nonsense-mediated decay underlies association with risk of severe COVID-19
medRxiv 2021cited by 12position: middledoi
Response to Li and Hopper
The American Journal of Human Genetics 2021cited by 5position: middledoi
Abstract 881: Benchmarking genome-wide polygenic risk score development techniques in colorectal cancer risk prediction
Cancer Research 2021cited by 0position: middledoi
Genome-wide Modeling of Polygenic Risk Score in Colorectal Cancer Risk
The American Journal of Human Genetics 2020cited by 225position: middledoi
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
BMC Medicine 2020cited by 177position: middledoi
Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects
Gastroenterology 2020cited by 62position: middledoi
Adiposity, metabolites, and colorectal cancer risk: Mendelian randomization study
medRxiv 2020cited by 20position: middledoi
Genetic architectures of proximal and distal colorectal cancer are partly distinct
medRxiv 2020cited by 10position: middledoi
Hemochromatosis risk genotype is not associated with colorectal cancer or age at its diagnosis
Human Genetics and Genomics Advances 2020cited by 5position: middledoi
Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer
Gastroenterology 2019cited by 194position: middledoi
Circulating Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor Binding Protein 3 Associate With Risk of Colorectal Cancer Based on Serologic and Mendelian Randomization Analyses
Gastroenterology 2019cited by 143position: middledoi
Discovery of common and rare genetic risk variants for colorectal cancer
Nature Genetics 2018cited by 600position: middledoi
Implementing universal Lynch syndrome screening (IMPULSS): protocol for a multi-site study to identify strategies to implement, adapt, and sustain genomic medicine programs in different organizational contexts
BMC Health Services Research 2018cited by 62position: middledoi
Association Between Molecular Subtypes of Colorectal Cancer and Patient Survival
Gastroenterology 2014cited by 407position: middledoi
Human Papillomavirus DNA Is Rarely Detected in Colorectal Carcinomas and Not Associated with Microsatellite Instability: The Seattle Colon Cancer Family Registry
Cancer Epidemiology Biomarkers & Prevention 2012cited by 29position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Polly A. Newcomb · University of Washington4 papers (2012–2021)Jeffrey K. Lee · Kaiser Permanente2 papers (2021–2021)Deborah Cragun · University of Illinois Chicago2 papers (2018–2023)Ravi Sharaf · Cornell University2 papers (2018–2023)Marc S. Williams · Genomic Health (United States)2 papers (2018–2023)Jessica Ezzell Hunter · New York University2 papers (2018–2023)Alanna Kulchak Rahm · National Institutes of Health2 papers (2018–2023)Douglas A. Corley · Kaiser Permanente San Francisco Medical Center2 papers (2021–2022)John D. Potter · University of Washington Applied Physics Laboratory2 papers (2012–2014)Mara M. Epstein · University of Massachusetts Chan Medical School2 papers (2018–2023)Su‐Ying Liang · Palo Alto Institute2 papers (2018–2023) · 2 papers (2018–2023)Pamala A. Pawloski · Georgetown University2 papers (2018–2023)Tim Waterboer · German Cancer Research Center1 papers (2012–2012)Jing Hao · People's Hospital of Cangzhou1 papers (2018–2018)Michael Pawlita · Heidelberg University1 papers (2012–2012)Mark A. Jenkins · Georgia Southern University1 papers (2021–2021)Rachel L. Winer · Seattle University1 papers (2022–2022)Jennifer L. Schneider · Seattle Children's Hospital1 papers (2023–2023)Graham Casey · University of Virginia1 papers (2021–2021)